The Hong Kong Jockey Club Global Health Institute (HKJCGHI) is an international partnership between the International Vaccine Institute (IVI), the University of Cambridge (UCAM) and The University of Hong Kong (HKU).

 

Established on March 1, 2024, with the generous support of the Hong Kong Jockey Club Charities Trust, the Institute aims to enhance global preparedness for future pandemics by advancing vaccine research, development, and implementation. The HKJCGHI will benefit from IVI's expansive network of field sites across the globe and expertise in vaccine development and delivery, HKU's leadership in pandemic virology and epidemiology, and UCAM's strength in assessing and optimising human immune responses. Together, it will unite world-leading scientists and research teams to foster collaboration and innovation in vaccine research.​​​

​

Funded by: